Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
- PMID: 11040002
- PMCID: PMC1729476
- DOI: 10.1136/heart.84.5.476
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
Abstract
Objective: To make a quantitative assessment of the relation between disarray, fibrosis, and small vessel disease in hypertrophic cardiomyopathy.
Design: Detailed macroscopic and histological examination at 19 segments of the left and right ventricle and the left atrial free wall.
Patients: 72 patients with hypertrophic cardiomyopathy who had suffered sudden death or progression to end stage cardiac failure (resulting in death or heart transplantation).
Main outcome measures: The presence of scarring, atrial dilatation, and a mitral valve impact lesion were noted, and heart weight, wall thickness, per cent disarray, per cent fibrosis, and per cent small vessel disease quantitated for each heart.
Results: Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002). Overall, however, total heart weight related weakly but significantly to fibrosis (r = 0.4, p = 0.0001) and small vessel disease (r = 0.3, p = 0.03), but not to disarray. Disarray was greater in hearts with mild left ventricular hypertrophy (maximum wall thickness < 20 mm) and preserved systolic function (60.9 (26)% v 43 (20.4)% respectively, p = 0.02) and hearts without a mitral valve impact lesion (26.3% v 18.9%, p = 0.04), but was uninfluenced by sex. Fibrosis was influenced by sex (7% in male patients and 4% in female, p = 0.04), but not by the presence of an impact lesion. No relation was found between disarray, fibrosis, and small vessel disease.
Conclusions: Myocyte disarray is probably a direct response to functional or structural abnormalities of the mutated sarcomeric protein, while fibrosis and small vessel disease are secondary phenomena unrelated to disarray, but modified by factors such as left ventricular mass, sex, and perhaps local autocrine factors.
Figures





Similar articles
-
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.Am J Cardiol. 2001 Aug 1;88(3):275-9. doi: 10.1016/s0002-9149(01)01640-x. Am J Cardiol. 2001. PMID: 11472707
-
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.Circulation. 2001 Sep 18;104(12):1380-4. doi: 10.1161/hc3701.095952. Circulation. 2001. PMID: 11560853
-
Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.Br Heart J. 1986 Jun;55(6):575-81. doi: 10.1136/hrt.55.6.575. Br Heart J. 1986. PMID: 3718796 Free PMC article.
-
Contractile Dysfunction in Sarcomeric Hypertrophic Cardiomyopathy.J Card Fail. 2016 Sep;22(9):731-7. doi: 10.1016/j.cardfail.2016.03.020. Epub 2016 May 16. J Card Fail. 2016. PMID: 27090746 Review.
-
[Myocardial interstitial fibrosis and diastolic dysfunction in hypertrophic cardiomyopathy].Ital Heart J Suppl. 2003 Aug;4(8):645-50. Ital Heart J Suppl. 2003. PMID: 14655460 Review. Italian.
Cited by
-
Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?J Nucl Cardiol. 2019 Aug;26(4):1125-1134. doi: 10.1007/s12350-018-1298-4. Epub 2018 May 14. J Nucl Cardiol. 2019. PMID: 29761309 Review.
-
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.J Transl Med. 2015 Sep 24;13:314. doi: 10.1186/s12967-015-0672-0. J Transl Med. 2015. PMID: 26404540 Free PMC article.
-
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.Cardiovasc Res. 2024 Jul 2;120(8):914-926. doi: 10.1093/cvr/cvae086. Cardiovasc Res. 2024. PMID: 38646743 Free PMC article.
-
Right ventricular dysfunction and long-term risk of death.Cardiovasc Diagn Ther. 2020 Oct;10(5):1646-1658. doi: 10.21037/cdt-20-450. Cardiovasc Diagn Ther. 2020. PMID: 33224778 Free PMC article. Review.
-
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.J Am Coll Cardiol. 2024 Nov 12;84(20):1999-2011. doi: 10.1016/j.jacc.2024.07.043. Epub 2024 Oct 2. J Am Coll Cardiol. 2024. PMID: 39365226
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical